Thienopyridones as AMPK activators for the treatment of diabetes and obesity
The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.
-
Page/Page column 62
(2010/02/10)
More Articles about upstream products of 844502-01-8